Bjørn Henning Grønberg

12PUBLICATIONS
53CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Epidemiological modellingPredictive and prognostic markersHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jul 13, 2026
Osimertinib Plus Gefitinib in Patients with EGFR-Mutated Advanced Non-Small Cell Lung Cancer and EGFR (C797X) Mutation Following First-Line Osimertinib: ORCHARD.

|Mar 19, 2026
How does pulmonary function impact QoL in patients with locally advanced NSCLC treated with chemoradiotherapy and durvalumab?

Frigg Å Sommervoll, Henrik Horndalsveen, Dag Einar Sommervoll

|Mar 24, 2023
Edmonton Frail Scale predicts mortality in older patients with cancer undergoing radiotherapy-A prospective observational study.

Inga Marie Røyset, Guro Falk Eriksen, Jūratė Šaltytė Benth

|Nov 04, 2022
Atezolizumab and stereotactic body radiotherapy in patients with advanced non-small cell lung cancer: safety, clinical activity and ctDNA responses-the ComIT-1 trial.

Henrik Horndalsveen, Tine Norman Alver, Astrid Marie Dalsgaard

|May 28, 2022
Associations between Measured and Patient-Reported Physical Function and Survival in Advanced NSCLC.

Kristin Stokke, Tarje Onsøien Halvorsen, Bjørn Henning Grønberg

|Dec 07, 2021
Geriatric impairments are prevalent and predictive of survival in older patients with cancer receiving radiotherapy: a prospective observational study.

Guro Falk Eriksen, Jūratė Šaltytė Benth, Bjørn Henning Grønberg

Pageof 2

Frequent Collaborators

4 joint publications

Tarje Onsøien Halvorsen

3 joint publications

Marit Slaaen

2 joint publications

Åslaug Helland

2 joint publications

Vilde Drageset Haakensen